Posted in | News | Non-Ferrous Alloys and Metals | Precious Metal

Heidelberg Cement welcome Takeover Bid from Spohn Cement

Jul 11 2005

Related Stories

The Managing Board and Supervisory Board of HeidelbergCement AG have commented on the takeover bid from Spohn Cement GmbH in separate statements published today . In its thoroughly justified statement, the Managing Board welcomes the takeover bid. It feels strengthened and supported in its strategy by the aims of Spohn Cement as expressed in the bid document.

The Managing Board regards the bid price of EUR 60 per share as adequate. It bases this on a fairness opinion issued by the investment bank Goldman Sachs. The fairness opinion is appended to the published statement, with an indication of the assumptions and limitations to which it is subject.

In a separate statement, the Supervisory Board concurred with the Managing Board’s assessment of the takeover bid.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback